» Articles » PMID: 15033813

Molecular Mechanisms for Cardiovascular Stem Cell Apoptosis and Growth in the Hearts with Atherosclerotic Coronary Disease and Ischemic Heart Failure

Overview
Specialty Science
Date 2004 Mar 23
PMID 15033813
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

In the heart with atherosclerotic coronary disease, chronic ischemia causes progressive loss of cardiovascular cells and ultimately triggers myocardial dysfunctions or heart failure. Various types of stem cells from embryonic and adult tissues have potentials for regenerating functional cardiovascular cells in the heart undergoing ischemic injury. However, native or exogenous stem cells in the ischemic hearts are exposed to various proapoptotic or cytotoxic factors. Furthermore, during repopulation and differentiation, certain numbers of newly produced cells may die by apoptosis during neocardiovascular tissue remodeling and morphogenesis. Embryonic and adult stem cells may have different life spans, as being programmed genetically to apoptosis. The endogenous and environmental factors play important roles in regulation of stem cells, including inflammatory cytokines, growth factors, surface receptors, proteolytic enzymes, mitochondrial respiration, nuclear proteins, telomerase activities, hypoxia-responding proteins, and stem cell-host cell interaction. Clarification of the molecular mechanisms may help us understand and design stem cell therapies.

Citing Articles

Apoptotic mesenchymal stem cells and their secreted apoptotic extracellular vesicles: therapeutic applications and mechanisms.

Wang R, Fu J, He J, Wang X, Xing W, Liu X Stem Cell Res Ther. 2025; 16(1):78.

PMID: 39985021 PMC: 11846181. DOI: 10.1186/s13287-025-04211-x.


Pretreatment with Notoginsenoside R1 enhances the efficacy of neonatal rat mesenchymal stem cell transplantation in model of myocardial infarction through regulating PI3K/Akt/FoxO1 signaling pathways.

Cai H, Han X, Luo Z, Wang Q, Lu P, Mou F Stem Cell Res Ther. 2024; 15(1):419.

PMID: 39533348 PMC: 11558819. DOI: 10.1186/s13287-024-04039-x.


Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases.

Gou T, Hu M, Xu M, Chen Y, Chen R, Zhou T J Pharm Anal. 2023; 13(6):563-589.

PMID: 37440909 PMC: 10334359. DOI: 10.1016/j.jpha.2023.05.010.


Microvessels derived from hiPSCs are a novel source for angiogenesis and tissue regeneration.

Gao X, Ma S, Xing X, Yang J, Xu X, Liang C J Tissue Eng. 2023; 13:20417314221143240.

PMID: 36600998 PMC: 9806436. DOI: 10.1177/20417314221143240.


A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs.

Lu Y, Wang D, Zhu Y, Du Y, Zhang J, Yang H Front Pharmacol. 2022; 13:1039857.

PMID: 36518671 PMC: 9744324. DOI: 10.3389/fphar.2022.1039857.